BRUNI, Alessio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.209
AS - Asia 4.323
EU - Europa 1.668
SA - Sud America 631
Continente sconosciuto - Info sul continente non disponibili 124
AF - Africa 73
OC - Oceania 7
Totale 12.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.872
CN - Cina 1.335
SG - Singapore 1.145
IT - Italia 764
VN - Vietnam 502
BR - Brasile 474
HK - Hong Kong 368
BD - Bangladesh 285
KR - Corea 223
GB - Regno Unito 187
TR - Turchia 163
FI - Finlandia 133
CA - Canada 131
DE - Germania 102
SE - Svezia 89
FR - Francia 81
IN - India 70
ID - Indonesia 59
MX - Messico 56
RU - Federazione Russa 56
AR - Argentina 53
UA - Ucraina 44
NL - Olanda 39
ES - Italia 30
CO - Colombia 28
BG - Bulgaria 26
IQ - Iraq 25
JP - Giappone 25
HN - Honduras 24
CR - Costa Rica 23
EC - Ecuador 22
PL - Polonia 21
BE - Belgio 20
CL - Cile 20
GT - Guatemala 17
PK - Pakistan 17
ZA - Sudafrica 17
MY - Malesia 14
SV - El Salvador 14
AE - Emirati Arabi Uniti 13
GP - Guadalupe 13
IE - Irlanda 12
IL - Israele 12
VE - Venezuela 12
TT - Trinidad e Tobago 11
DZ - Algeria 10
LT - Lituania 10
PY - Paraguay 10
SA - Arabia Saudita 10
EG - Egitto 9
PR - Porto Rico 9
CW - ???statistics.table.value.countryCode.CW??? 8
KE - Kenya 8
NI - Nicaragua 8
JM - Giamaica 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
AL - Albania 6
AU - Australia 6
HU - Ungheria 6
RO - Romania 6
TH - Thailandia 6
TN - Tunisia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
JO - Giordania 5
PA - Panama 5
AT - Austria 4
BZ - Belize 4
CZ - Repubblica Ceca 4
IR - Iran 4
MA - Marocco 4
QA - Qatar 4
RS - Serbia 4
UZ - Uzbekistan 4
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PT - Portogallo 3
SC - Seychelles 3
SN - Senegal 3
TG - Togo 3
BB - Barbados 2
BS - Bahamas 2
CH - Svizzera 2
CY - Cipro 2
HT - Haiti 2
MQ - Martinica 2
SI - Slovenia 2
TW - Taiwan 2
UY - Uruguay 2
AD - Andorra 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
Totale 11.896
Salva come PNG Salva come JPEG
Città #
Hefei 779
Ashburn 773
Singapore 640
San Jose 446
Council Bluffs 414
Hong Kong 358
Santa Clara 307
Seoul 222
Fairfield 213
Ho Chi Minh City 169
Istanbul 131
Los Angeles 130
Hanoi 126
Beijing 125
Helsinki 121
Boardman 97
Houston 94
New York 92
Milan 86
Wilmington 80
Chicago 79
Chandler 76
London 76
Woodbridge 76
Seattle 75
Shanghai 66
Lauterbourg 64
Buffalo 63
Cambridge 63
Dallas 63
Rome 56
Modena 53
Kent 46
Southend 41
Nyköping 38
São Paulo 38
Phoenix 36
The Dalles 36
Naples 35
Mexico City 30
Orem 30
Salt Lake City 30
Montreal 28
Princeton 26
Ann Arbor 25
Da Nang 24
Jakarta 24
North Bergen 23
San Diego 23
Toronto 22
Bologna 21
Sofia 21
Turin 21
Dearborn 20
Denver 19
Frankfurt am Main 19
Haiphong 19
Tokyo 19
Atlanta 18
Jacksonville 18
Brooklyn 17
Warsaw 17
Miami 16
Chennai 15
San Francisco 15
San José 15
Dhaka 14
Florence 14
Las Vegas 14
Leuven 14
Munich 14
Reggio Emilia 14
Biên Hòa 13
Nuremberg 13
San Salvador 13
Elk Grove Village 12
Johannesburg 12
Lappeenranta 12
Palermo 12
Rio de Janeiro 12
Washington 12
Baghdad 11
Eugene 11
Guatemala City 11
Osasco 11
Poplar 11
San Pedro Sula 11
Santiago 11
Tampa 11
Brasília 10
Charlotte 10
Izmir 10
Saint Augustine 10
Shenzhen 10
Brescia 9
Columbus 9
Curitiba 9
Guangzhou 9
Manchester 9
Miano 9
Totale 7.445
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 368
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 344
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 319
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 296
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 290
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 276
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 248
SIS epidemiological model for adaptive RT: Forecasting the parotid glands shrinkage during tomotherapy treatment 234
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 230
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC 214
Pineoblastoma in Adults: A Rare Case Successfully Treated with Multimodal Approach Including Craniospinal Irradiation Using Helical Tomotherapy 208
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 207
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 189
Lattice Radiation Therapy in clinical practice: A systematic review 179
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 177
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study 175
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients 174
Oligorecurrent Non-Small-Cell Lung Cancer Treated by Chemo-Radiation Followed by Immunotherapy and Intracranial Radiosurgery: A Case Report and Mini Review of Literature 171
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 169
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 165
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis 163
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 162
Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation 162
Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial 160
Current radiotherapy techniques in NSCLC: challenges and potential solutions 152
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 151
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial 150
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 150
A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC 149
The role of postoperative radiotherapy for thymomas: a multicentric retrosepective evaluation from three Italian centers and review of the literature. 144
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 142
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 140
Guidelines on prostate carcinoma - AIRO, 2016 139
Non-invasive approach to treat primary solid solitary pulmonary nodule: a narrative review by the radiation oncologist perspective 136
Quality of life after prostate cancer diagnosis: Data from the Pros-IT CNR 136
Erratum: The role of postoperative radiotherapy for thymomas: A multicentric retrospective evaluation from three Italian centers and review of the literature (Journal of Thoracic Disease (2020) 12 (7518-7530) DOI: 10.21037/jtd-2019-thym-09) 136
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 135
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study 134
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 132
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 131
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 129
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 127
How has prostate cancer radiotherapy changed in Italy between 2004 and 2011? An analysis of the national patterns-of-practice (pop) database by the uro-oncology study group of the italian society of radiotherapy and clinical oncology (airo) 125
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 122
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 122
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 122
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 122
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 122
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach 119
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 119
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC 118
Response to Letter to the Editor Titled “Surgery or Stereotactic Body Radiotherapy for Early Stage Lung Cancer: What is the Current Evidence?” 115
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 114
Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach 114
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 114
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings 112
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 112
Radiosurgery Using Tomotherapy for Patients with Brain Oligo-metastasis: A Retrospective Analysis on Feasibility and Tolerance 110
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy 108
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 106
Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience 104
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 100
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 99
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 99
Brain metastases from primary colorectal cancer: Is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO) 99
Reirradiation in head and neck recurrent or second primary tumor: Efficacy, safety, and prognostic factors 98
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 95
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer 89
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719) 88
Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)—Lung Working Group 88
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 88
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 87
Post-operative radiotherapy in N2 non-small cell lung cancer: A retrospective analysis of 175 patients 86
Management of Stage II testicular seminoma over a period of 40 years 85
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 85
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: The impact of thoracic and brain irradiation on survival 84
Radiation therapy in small cell lung cancer: a national Italian survey 83
SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial 79
Oral ibandronate in metastatic bone breast cancer: The Florence University experience and a review of the literature 78
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: A retrospective analysis 75
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC Study 69
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial) 67
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 62
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 58
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial 30
Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices 27
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial 26
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study 18
Totale 12.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022291 0 0 0 0 14 25 27 31 39 31 93 31
2022/2023294 38 37 40 15 40 31 5 20 40 2 10 16
2023/2024257 18 13 24 31 21 12 22 40 8 15 15 38
2024/20251.715 30 2 17 62 158 133 46 78 171 314 355 349
2025/20266.383 505 406 702 791 607 406 609 305 662 457 491 442
2026/20272.221 241 450 386 851 293 0 0 0 0 0 0 0
Totale 12.035